Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
CA: a Cancer Journal for Clinicians|August 24, 2021
Brain and other central nervous system tumor statistics, 2021Kimberly D Miller, Quinn T Ostrom, Carol Kruchko, et al.Journal of Neuro-Oncology|November 19, 2023
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECTMackenzie Price, Corey Neff, Carol Kruchko, et al.Neuro-Oncology Advances|January 27, 2021
The brain tumor not-for-profit and charity experience of COVID-19: reacting and adjusting to an unprecedented global pandemic in the 21st centuryChristina Amidei, Jean Arzbaecher, Mary Ellen Maher, et al.Neuro-Oncology|December 28, 2014
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011Quinn T Ostrom, Peter M de Blank, Carol Kruchko, et al.Frontiers in Public Health|August 6, 2016
Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based RegistryLi-Nien Chien, Haley Gittleman, Quinn T Ostrom, et al.Neuro-Oncology|August 13, 2021
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomasGi-Ming Wang, Gino Cioffi, Nirav Patil, et al.Cancer Epidemiology|September 7, 2024
The intersection of race, ethnicity, and urbanicity on treatment paradigms and clinical outcomes for non-malignant primary tumors of the spineBrandon Bishop, Harrison Hockenberry, Jacob Sperber, et al.Neuro-Oncology|August 8, 2012
Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registriesBridget J McCarthy, Soichiro Shibui, Takamasa Kayama, et al.Cancer|September 11, 2025
Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010-2019Diana R Withrow, Joseph Boyle, Martha S Linet, et al.Neuro-Oncology Advances|January 28, 2021
An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results ProgramGonçalo Forjaz, Jill S Barnholtz-Sloan, Carol Kruchko, et al.Pageof 12